The Role of Olmesartan Medoxomil in the Management of Hypertension
Authors:
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 64 (24) , 2731-2739
Abstract
Intensive blood pressure control is a desirable and obtainable goal in patients with hypertension, according to the most recent treatment guidelines from Europe and the US. Achieving target blood pressure depends on the efficacy of antihypertensive treatment and patient compliance. Olmesartan medoxomil, a non-peptidergic angiotensin AT1 receptor antagonist, has been shown to be effective and well tolerated. Continuation of initial treatment is higher with AT1 receptor antagonists than for any other class of antihypertensive drugs. Olmesartan medoxomil may also have end-organ protective effects that provide additional clinical benefit. Optimal blood pressure control may be achieved faster if initial treatment contains the most efficacious and well tolerated antihypertensive drug or drugs. The ongoing European study, known as OLMEBEST (Efficacy and safety of OLMEsartan: reduction of Blood pressure in the treatment of patients suffering from mild to moderate ESsenTial hypertension), will provide important information on the use of olmesartan medoxomil as an initial treatment for hypertension.Keywords
This publication has 43 references indexed in Scilit:
- Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control?Clinical Therapeutics, 2004
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- The Study on Cognition and Prognosis in the Elderly (SCOPE)Journal Of Hypertension, 2003
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classesClinical Therapeutics, 2001
- Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US HypertensivesHypertension, 2001
- Detection and Control of High Blood Pressure in the CommunityHypertension, 1999
- The Hypertension Optimal Treatment (HOT) Study: 24-month Data on Blood Pressure and TolerabilityBlood Pressure, 1997
- Framingham Study Insights into Hypertensive Risk of Cardiovascular Disease.Hypertension Research, 1995
- Mortality in Patients of the Glasgow Blood Pressure ClinicJournal Of Hypertension, 1986